Us Japan And Europe Computer Aided Detection Cad Market
Размер рынка в млрд долларов США
CAGR :
% 
 Прогнозируемый период |
2025 –2031 |
 Размер рынка (базовый год) |
|
 Размер рынка (прогнозируемый год) |
USD 3,609.06 |
 CAGR |
% |
| Основные игроки рынка |
Рынок систем автоматизированного обнаружения (САПР) в США, Японии и Европе по типу продукта (программное обеспечение и услуги), модальности визуализации (визуализация молочной железы, визуализация легких, онкология и лучевая терапия, визуализация брюшной полости и таза, стоматологическая визуализация, сердечно-сосудистая визуализация и другие), области применения (рак, неврологические расстройства, сердечно-сосудистые заболевания, заболевания опорно-двигательного аппарата и другие), способу покупки (групповые закупки, организации и частные лица), конечный пользователь (больницы, диагностические центры, научно-исследовательские институты и академические центры и другие) — тенденции отрасли и прогноз до 2031 года.
Анализ и размер рынка систем автоматизированного обнаружения (САПР) в США, Японии и Европе
Ожидается, что рынок систем автоматизированного обнаружения (САПР) в США, Японии и Европе будет расти в прогнозируемый период с 2024 по 2031 год.
По данным исследования рынка Data Bridge, среднегодовой темп роста рынка составит 12% в прогнозируемый период с 2024 по 2031 год, и ожидается, что к 2031 году его объем достигнет 3 609,06 млн долларов США. Ожидается, что растущий спрос на системы САПР будет способствовать расширению рынка.
|
Отчет Метрика |
Подробности |
|
Прогнозируемый период |
2024-2031 |
|
Базовый год |
2023 |
|
Исторический год |
2022 (настраиваемый 2016-2021) |
|
Количественные единицы |
Доход в млн. долл. США и цены в долл. США |
|
Охваченные сегменты |
Тип продукта (программное обеспечение и услуги), модальность визуализации ( визуализация молочной железы , визуализация легких, онкология и лучевая терапия, визуализация брюшной полости и таза, стоматологическая визуализация, сердечно-сосудистая визуализация и другие), применение (рак, неврологические расстройства, сердечно-сосудистые заболевания, заболевания опорно-двигательного аппарата и другие), способ покупки (групповая закупка, организация и физическое лицо), конечный пользователь (больницы, диагностические центры, научно-исследовательские институты и академические центры и другие) |
|
Страны, охваченные |
США, Япония, Германия, Италия, Великобритания, Франция, Швейцария, Испания, Россия, Турция, Бельгия, Нидерланды и остальная Европа |
|
Охваченные участники рынка |
CANON MEDICAL SYATEMA CORPORATION, Riverain Technologies, Koninklijke Philips NV, Seimens Healthineers AG, Hologic Inc., FUJIFILM Holdings Corporation, Median Technologies, General Electric Company, iCAD и Inc., EDDA Technology, Inc. и другие |
Определение рынка
Термин «компьютерное обнаружение» (САПР) описывает процесс интерпретации медицинских изображений, таких как рентгеновские снимки, КТ и МРТ, с использованием компьютерных алгоритмов и программного обеспечения. Области интереса или возможные аномалии на изображениях выделяются и помечаются системами САПР, чтобы рентгенолог или другой поставщик медицинских услуг мог исследовать их более подробно. Эти системы анализируют закономерности, формы и плотности на изображениях для повышения эффективности и точности диагностики, выделяя области, которые могут потребовать более тщательного обследования. САПР является полезным инструментом в процессе диагностики, который помогает медицинским специалистам понимать и принимать решения, даже если он не может заменить человеческие навыки.
Динамика рынка систем автоматизированного обнаружения (САПР) в США, Японии и Европе
В этом разделе рассматривается понимание движущих сил рынка, преимуществ, возможностей, ограничений и проблем. Все это подробно обсуждается ниже:
Драйверы
Растущее применение систем автоматизированного обнаружения (САПР) в медицинской сфере
Рынок систем автоматизированного обнаружения (САПР) растет и развивается из-за растущего внедрения этих систем в различных медицинских дисциплинах. Системы САПР широко использовались в радиологии для определения сложностей на изображениях, таких как маммограммы, но они быстро распространились на многие другие медицинские специальности. Растущее использование систем САПР в областях специализации, отличных от радиологии — патологии, кардиологии, онкологии и неврологии — указывает на их адаптивность и эффективность в поддержке медицинского персонала в различных дисциплинах. Процедуры здравоохранения революционизируются благодаря способности САПР обеспечивать раннюю идентификацию, точную диагностику и планирование лечения для различных заболеваний.
Растущее внедрение и использование систем CAD в ряде медицинских специальностей подчеркивает их революционное влияние на предоставление медицинских услуг. Использование этих систем в различных специализациях растет, поскольку они показывают перспективы в содействии более ранней и точной диагностике, улучшении результатов лечения и улучшении ухода за пациентами. Таким образом, растущее применение систем CAD в медицинской сфере стимулирует рост рынка.
- Растущий технологический прогресс, связанный с САПР
Основным фактором роста и расширения рынка автоматизированного обнаружения (САПР) в секторе здравоохранения являются технологические усовершенствования. Эти разработки поддерживают системы САПР в актуальном состоянии и повышают их адаптивность, точность и способность диагностировать широкий спектр медицинских расстройств. Разработка алгоритмов глубокого обучения, машинного обучения и искусственного интеллекта (ИИ) имеет важное значение для развития систем САПР. Эти разработки позволяют программному обеспечению САПР обрабатывать огромные объемы данных медицинских изображений с ранее невиданной скоростью и точностью. Это приводит к более точной и надежной идентификации аномалий в МРТ, КТ, рентгеновских снимках и других методах визуализации.
Системы САПР будут совершенствоваться в плане обнаружения, адаптивности и интеграции с экосистемами здравоохранения по мере дальнейшего развития технологий. Рынок растет в результате неуклонного применения индустрией САПР технологических улучшений, которые обладают огромным потенциалом для революционного изменения ухода за пациентами, улучшения диагностических возможностей и влияния на направление здравоохранения. Таким образом, растущие технологические достижения являются движущей силой роста рынка.
Возможности
- Развитая инфраструктура здравоохранения стран
Развитая инфраструктура здравоохранения в США, Японии и Европе является фактором создания значительных возможностей на рынке. В США хорошо налаженная сеть больниц и диагностических центров в сочетании с современными медицинскими учреждениями обеспечивает плодородную почву для бесшовной интеграции технологий САПР. Надежная инфраструктура ускоряет внедрение систем САПР, повышая эффективность и точность медицинской визуализации и диагностики.
Во всех трех регионах передовая инфраструктура здравоохранения не только создает основу для внедрения CAD, но и отражает приверженность использованию передовых технологий для улучшения ухода за пациентами. Эта приверженность в сочетании с технологической готовностью систем здравоохранения создает среду, в которой CAD может процветать, предлагая передовые диагностические возможности, которые способствуют более точным и своевременным медицинским вмешательствам, что, как ожидается, создаст возможности для роста рынка.
Ограничения/Вызов
- Высокая стоимость систем автоматизированного обнаружения (САПР)
Многие медицинские учреждения испытывают трудности с интеграцией систем CAD в свои диагностические рабочие процессы из-за первоначальных инвестиций, необходимых для приобретения и внедрения системы CAD. Для систем CAD часто требуется специфическое для медицинской визуализации аппаратное и программное обеспечение. Эти системы могут иметь высокие первоначальные затраты, особенно для небольших медицинских учреждений или тех, у кого ограниченный бюджет.
Общая стоимость владения включает дополнительные расходы на постоянное обслуживание, обновления и лицензирование после первоначальных расходов. Стоимость увеличивается из-за необходимости обеспечения соответствия системы новым разработкам и требованиям законодательства. Требуется больше времени и ресурсов для обучения работников здравоохранения эффективному использованию систем САПР и их бесшовной интеграции в текущие операции. Существуют расходы, связанные с этим обучением как для первоначального развертывания, так и для постоянного обучения по мере выпуска новых функций или обновлений.
Поставщики медицинских услуг, особенно небольшие практики или учреждения с ограниченными средствами, неохотно используют системы CAD из-за их высокой стоимости. Доступ пациентов к преимуществам более точной и эффективной диагностики систем CAD ограничен этим барьером принятия. Финансовые ресурсы учреждений здравоохранения, особенно небольших практик или учреждений с ограниченными ресурсами, напряжены из-за кумулятивного эффекта расходов на техническое обслуживание. Таким образом, высокая стоимость систем автоматизированного обнаружения (САПР) сдерживает рост рынка.
Масштаб рынка систем автоматизированного обнаружения (САПР) в США, Японии и Европе
Рынок систем автоматизированного обнаружения (САПР) в США, Японии и Европе делится на пять основных сегментов в зависимости от типа продукта, метода получения изображений, способа покупки и конечного пользователя.
Тип продукта
- Программное обеспечение
- Услуги
По типу продукта рынок сегментирован на программное обеспечение и услуги.
Модальность визуализации
- Визуализация груди
- Визуализация легких
- Онкология и радиация
- Визуализация брюшной полости и таза
- Дентальная визуализация
- Сердечно-сосудистая визуализация
- Другие
По методу визуализации рынок сегментирован на визуализацию молочных желез, легких, онкологию и лучевую терапию, брюшную полость и таз, стоматологическую визуализацию, сердечно-сосудистую визуализацию и другие.
Приложение
- Рак
- Неврологические расстройства
- Сердечно-сосудистые заболевания
- Заболевания опорно-двигательного аппарата
- Другие
По сфере применения рынок сегментируется на онкологические заболевания, неврологические расстройства, сердечно-сосудистые заболевания, заболевания опорно-двигательного аппарата и другие.
Способ покупки
- Организация групповых закупок
- Индивидуальный
По способу совершения покупок рынок сегментируется на организации, осуществляющие групповые покупки, и индивидуальные покупки.
Конечный пользователь
- Больницы
- Диагностические центры
- Научно-исследовательские институты и академические центры
- Другие
По признаку конечного пользователя рынок сегментируется на больницы, диагностические центры, научно-исследовательские институты и академические центры и т. д.
Региональный анализ/информация о рынке автоматизированного обнаружения (САПР) в США, Японии и Европе
Проведен анализ рынка систем автоматизированного обнаружения (САПР) в США, Японии и Европе, а также предоставлены сведения о размерах рынка и тенденциях на основе типа продукта, модальности визуализации, области применения, способа покупки и конечного пользователя.
В отчете о рынке систем автоматизированного обнаружения (САПР) в США, Японии и Европе рассматриваются следующие страны: США, Германия, Италия, Великобритания, Франция, Швейцария, Испания, Россия, Турция, Бельгия, Нидерланды и остальные страны Европы.
Ожидается, что США будут доминировать на североамериканском рынке, поскольку США являются одним из крупнейших в мире производителей систем САПР. Ожидается, что Япония будет доминировать на рынке Азиатско-Тихоокеанского региона, поскольку имеет долгую историю медицинских технологий. Ожидается, что Германия будет доминировать на рынке, поскольку немецкие медицинские специалисты часто используют современные и эффективные методы САПР, что может привести к более высоким продажам и более качественному САПР.
Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании рынка, которые влияют на текущие и будущие тенденции рынка. Такие данные, как анализ цепочки создания стоимости вверх и вниз по течению, технические тенденции и анализ пяти сил Портера, тематические исследования, являются некоторыми из указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность глобальных брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, влияние внутренних тарифов и торговых путей.
Конкурентная среда и анализ доли рынка автоматизированного обнаружения (САПР) в США, Японии и Европе
Конкурентная среда рынка автоматизированного обнаружения (САПР) в США, Японии и Европе содержит подробную информацию по конкурентам. Включены следующие сведения: обзор компании, финансовые показатели компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, глобальное присутствие, производственные площадки и объекты, производственные мощности, сильные и слабые стороны компании, запуск продукта, широта и широта продукта, доминирование приложений. Приведенные выше данные относятся только к фокусу компаний на рынке автоматизированного обнаружения (САПР) в США, Японии и Европе.
Некоторые из основных игроков, работающих на рынке систем автоматизированного сканирования (САПР) в США, Японии и Европе, включают CANON MEDICAL SYATEMA CORPORATION, Riverain Technologies, Koninklijke Philips NV, Seimens Healthineers AG, Hologic Inc., FUJIFILM Holdings Corporation, Median Technologies, General Electric Company, iCAD и Inc., EDDA Technology, Inc.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 MULTIVARIATE MODELLING
2.8 TYPE LIFELINE CURVE
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL
4.2 PORTERS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING APPLICATION OF COMPUTER-AIDED DETECTION (CAD) SYSTEM IN MEDICAL FIELD
5.1.2 INCREASING TECHNOLOGICAL ADVANCEMENTS ASSOCIATED WITH CAD
5.1.3 GOVERNMENT INITIATIVES FOR COMPUTER AIDED DETECTION (CAD) SYSTEMS
5.2 RESTRAINTS
5.2.1 HIGH COST OF COMPUTER AIDED DETECTION (CAD) SYSTEMS
5.2.2 STRICT GUIDELINES FOR COMPUTER AIDED DETECTION (CAD)
5.3 OPPORTUNITIES
5.3.1 ADVANCED HEALTHCARE INFRASTRUCTURE OF THE COUNTRIES
5.3.2 INCREASING AWARENESS REGARDING ACCURATE DIAGNOSIS
5.4 CHALLENGE
5.4.1 DEPENDENCY ON SKILLED MEDICAL PROFESSIONALS
6 US, JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 SOFTWARE
6.2.1 INTEGRATED CAD SYSTEMS
6.2.1.1 CLOUD BASED
6.2.1.2 ON PREMISES
6.2.2 STANDALONE CAD SYSTEMS
6.2.2.1 CLOUD BASED
6.2.2.2 ON PREMISES
6.3 SERVICES
7 US, JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY
7.1 OVERVIEW
7.2 ONCOLOGY AND RADIATION
7.2.1 BY TYPE
7.2.1.1 ONCOLOGY CAD
7.2.1.2 RADIATION THERAPY PLANNING
7.2.2 BY TUMOR TYPE
7.2.2.1 MALIGNANT
7.2.2.2 BENIGN
7.2.3 BY PRODUCT TYPE
7.2.3.1 SOFTWARE
7.2.3.2 SERVICES
7.3 BREAST IMAGING
7.3.1 BY TYPE
7.3.1.1 MAMMOGRAPHY CAD
7.3.1.2 BREAST ULTRASOUND CAD
7.3.2 BY PRODUCT TYPE
7.3.2.1 SOFTWARE
7.3.2.2 SERVICES
7.4 LUNG IMAGING
7.4.1 BY TYPE
7.4.1.1 CHEST X-RAY CAD
7.4.1.2 CHEST CT CAD ON PULMONARY NODULES
7.4.2 BY NODULE SIZE
7.4.2.1 >4MM AND <5MM
7.4.2.2 >5MM
7.4.2.3 3 MM AND < 4MM
7.4.3 BY NODULE
7.4.3.1 PART SOLID NODULES
7.4.3.2 NON- SOLID NODULES
7.4.4 BY NODULE TYPE
7.4.4.1 JUXTAPLEURAL NODULES
7.4.4.2 ISOLATED NODULES
7.4.4.3 GROUND-GLASS NODULES
7.4.5 BY PRODUCT TYPE
7.4.5.1 SOFTWARE
7.4.5.2 SERVICES
7.5 CARDIOVASCULAR IMAGING
7.5.1 BY TYPE
7.5.1.1 CARDIAC CT CAD
7.5.1.2 CARDIAC MT CAD
7.5.2 BY PRODUCT TYPE
7.5.2.1 SOFTWARE
7.5.2.2 SERVICES
7.6 ABDOMINAL AND PELVIC IMAGING
7.6.1 BY TYPE
7.6.1.1 GASTROINTESTINAL CAD
7.6.1.2 ABDOMINAL CT CAD
7.6.1.3 KIDNEY CAD
7.6.2 BY PRODUCT TYPE
7.6.2.1 SOFTWARE
7.6.2.2 SERVICES
7.7 DENTAL IMAGING
7.7.1 BY PRODUCT TYPE
7.7.1.1 SOFTWARE
7.7.1.2 SERVICES
7.8 OTHERS
8 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 CANCER
8.2.1 BY TYPE
8.2.1.1 BREAST CANCER
8.2.1.2 COLORECTAL CANCER
8.2.1.3 LUNG CANCER
8.2.1.4 PROSTATE CANCER
8.2.1.5 LIVER CANCER
8.2.1.6 BONE CANCER
8.2.1.7 OTHERS
8.2.2 BY PRODUCT TYPE
8.2.2.1 SOFTWARE
8.2.2.2 SERVICES
8.3 NEUROLOGICAL DISORDERS
8.3.1 BY TYPE
8.3.1.1 MULTIPLE SCLEROSIS
8.3.1.2 STROKE
8.3.1.3 OTHERS
8.3.2 BY PRODUCT TYPE
8.3.2.1 SOFTWARE
8.3.2.2 SERVICES
8.4 CARDIOVASCULAR DISEASES
8.4.1 BY TYPE
8.4.1.1 CORONARY ARTERY DISEASE
8.4.1.2 CONGENITAL HEART DEFECTS
8.4.1.3 VALVULAR HEART DISEASE
8.4.1.4 OTHERS
8.4.2 BY PRODUCT TYPE
8.4.2.1 SOFTWARE
8.4.2.2 SERVICES
8.5 MUSCULOSKELETAL DISEASES
8.5.1 BY TYPE
8.5.1.1 OSTEOARTHRITIS
8.5.1.2 RHEUMATOID ARTHRITIS
8.5.1.3 JOINT DISORDERS
8.5.1.4 OTHERS
8.6 OTHERS
9 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE
9.1 OVERVIEW
9.2 GROUP PURCHASE ORGANIZATIONS
9.3 INDIVIDUAL
10 US, JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 PRIVATE
10.2.2 PUBLIC
10.3 DIAGNOSTIC CENTERS
10.4 RESEARCH CENTERS & ACADEMIC INSTITUTES
10.5 OTHERS
11 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET BY REGION
11.1 EUROPE
11.1.1 GERMANY
11.1.2 FRANCE
11.1.3 U.K.
11.1.4 SPAIN
11.1.5 ITALY
11.1.6 NETHERLANDS
11.1.7 BELGIUM
11.1.8 SWITZERLAND
11.1.9 RUSSIA
11.1.10 TURKEY
11.1.11 REST OF EUROPE
12 COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: U.S., JAPAN & EUROPE
12.2 COMPANY SHARE ANALYSIS: U.S.
12.3 COMPANY SHARE ANALYSIS: JAPAN
12.4 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 KONINKLIJKE PHILIPS N.V.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENT
14.2 FUJIFILM HOLDINGS CORPORATION
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENT
14.3 CANON MEDICAL SYSTEMS CORPORATION
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENT
14.4 SIEMENS HEALTHINEERS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENT
14.5 MEDIAN TECHNOLOGIES.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.6 EDDA TECHNOLOGY, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 GENERAL ELECTRIC
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 HOLOGIC INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 ICAD, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENT
14.1 RIVERAIN TECHNOLOGIES
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Список таблиц
TABLE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2023- 2031 (USD MILLION)
TABLE 2 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2023-2031 (USD MILLION)
TABLE 3 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2023-2031 (USD MILLION)
TABLE 4 U.S. SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 5 JAPAN SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 6 EUROPE SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 7 U.S. INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 8 JAPAN INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 9 EUROPE INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 10 U.S. STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 11 JAPAN STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 12 EUROPE STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 13 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2023- 2031 (USD MILLION)
TABLE 14 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2023-2031 (USD MILLION)
TABLE 15 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2023-2031 (USD MILLION)
TABLE 16 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 17 JAPAN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 18 EUROPE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)
TABLE 19 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 20 JAPAN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 21 EUROPE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2021-2031 (USD MILLION)
TABLE 22 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 23 JAPAN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 24 EUROPE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2021-2031 (USD MILLION)
TABLE 25 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 26 JAPAN BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 27 EUROPE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)
TABLE 28 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 29 JAPAN BRESAT IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 30 EUROPE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)
TABLE 31 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 32 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 33 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)
TABLE 34 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 35 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 36 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2021-2031 (USD MILLION)
TABLE 37 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 38 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE , 2022-2031 (USD MILLION)
TABLE 39 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2021-2031 (USD MILLION)
TABLE 40 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 41 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 42 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2021-2031 (USD MILLION)
TABLE 43 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 44 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 45 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)
TABLE 46 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 47 JAPAN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 48 EUROPE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)
TABLE 49 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 50 JAPAN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 51 EUROPE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)
TABLE 52 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 53 JAPAN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 54 EUROPE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)
TABLE 55 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 56 JAPAN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 57 EUROPE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)
TABLE 58 U.S. DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 59 JAPAN DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 60 EUROPE DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)
TABLE 61 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2023- 2031 (U.S.D MILLION)
TABLE 62 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2023-2031 (U.S.D MILLION)
TABLE 63 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2023-2031 (U.S.D MILLION)
TABLE 64 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 65 JAPAN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 66 EUROPE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 67 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 68 JAPAN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 69 EUROPE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 70 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 71 JAPAN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 72 EUROPE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 73 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 74 JAPAN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 75 EUROPE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 76 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 77 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 78 JAPAN CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 79 EUROPE CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 80 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 81 JAPAN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 82 EUROPE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 83 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 84 JAPAN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 85 EUROPE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 86 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2023- 2031 (USD MILLION)
TABLE 87 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2023-2031 (USD MILLION)
TABLE 88 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2023-2031 (USD MILLION)
TABLE 89 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 90 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 91 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 92 U.S. HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 93 JAPAN HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 94 EUROPE HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 95 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 96 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 97 GERMANY SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 98 GERMANY INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 99 GERMANY STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 100 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 101 GERMANY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 102 GERMANY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 103 GERMANY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 104 GERMANY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 105 GERMANY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 106 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 107 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 108 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 109 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 110 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 111 GERMANY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 112 GERMANY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 113 GERMANY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 114 GERMANY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 115 GERMANY DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 116 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 117 GERMANY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 118 GERMANY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 119 GERMANY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 120 GERMANY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 121 GERMANY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 122 GERMANY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 123 GERMANY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 GERMANY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 125 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 126 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 127 GERMANY HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 128 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 129 FRANCE SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 130 FRANCE INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 131 FRANCE STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 132 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 133 FRANCE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 134 FRANCE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 135 FRANCE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 136 FRANCE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 137 FRANCE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 138 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 139 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 140 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 141 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 142 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 143 FRANCE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 144 FRANCE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 145 FRANCE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 146 FRANCE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 147 FRANCE DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 148 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 149 FRANCE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 150 FRANCE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 151 FRANCE CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 152 FRANCE CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 153 FRANCE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 154 FRANCE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 155 FRANCE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 156 FRANCE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 157 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 158 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 159 FRANCE HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 160 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 161 U.K. SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 162 U.K. INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 163 U.K. STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 164 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 165 U.K. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 166 U.K. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 167 U.K. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 168 U.K. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 169 U.K. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 170 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 171 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 172 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 173 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 174 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 175 U.K. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 176 U.K. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 177 U.K. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 178 U.K. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 179 U.K. DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 180 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 181 U.K. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 182 U.K. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 183 U.K. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 184 U.K. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 185 U.K. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 186 U.K. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 187 U.K. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 188 U.K. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 189 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 190 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 191 U.K. HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 192 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 193 SPAIN SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 194 SPAIN INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 195 SPAIN STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 196 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 197 SPAIN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 198 SPAIN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 199 SPAIN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 200 SPAIN BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 201 SPAIN BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 202 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 203 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 204 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 205 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 206 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 207 SPAIN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 208 SPAIN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 209 SPAIN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 210 SPAIN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 211 SPAIN DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 212 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 213 SPAIN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 214 SPAIN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 215 SPAIN CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 216 SPAIN CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 217 SPAIN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 218 SPAIN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 219 SPAIN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 220 SPAIN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 221 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 222 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 223 SPAIN HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 224 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 225 ITALY SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 226 ITALY INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 227 ITALY STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 228 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 229 ITALY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 230 ITALY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 231 ITALY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 232 ITALY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 233 ITALY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 234 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 235 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 236 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 237 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 238 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 239 ITALY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 240 ITALY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 241 ITALY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 242 ITALY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 243 ITALY DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 244 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 245 ITALY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 246 ITALY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 247 ITALY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 248 ITALY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 249 ITALY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 250 ITALY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 251 ITALY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 252 ITALY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 253 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 254 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 255 ITALY HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 256 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 257 NETHERLANDS SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 258 NETHERLANDS INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 259 NETHERLANDS STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 260 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 261 NETHERLANDS ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 262 NETHERLANDS ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 263 NETHERLANDS ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 264 NETHERLANDS BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 265 NETHERLANDS BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 266 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 267 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 268 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 269 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 270 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 271 NETHERLANDS CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 272 NETHERLANDS CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 273 NETHERLANDS ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 274 NETHERLANDS ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 275 NETHERLANDS DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 276 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 277 NETHERLANDS CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 278 NETHERLANDS CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 279 NETHERLANDS CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 280 NETHERLANDS CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 281 NETHERLANDS MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 282 NETHERLANDS MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 283 NETHERLANDS NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 284 NETHERLANDS NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 285 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 286 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 287 NETHERLANDS HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 288 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 289 BELGIUM SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 290 BELGIUM INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 291 BELGIUM STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 292 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 293 BELGIUM ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 294 BELGIUM ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 295 BELGIUM ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 296 BELGIUM BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 297 BELGIUM BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 298 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 299 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 300 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 301 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 302 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 303 BELGIUM CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 304 BELGIUM CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 305 BELGIUM ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 306 BELGIUM ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 307 BELGIUM DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 308 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 309 BELGIUM CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 310 BELGIUM CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 311 BELGIUM CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 312 BELGIUM CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 313 BELGIUM MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 314 BELGIUM MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 315 BELGIUM NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 316 BELGIUM NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 317 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 318 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 319 BELGIUM HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 320 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 321 SWITZERLAND SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 322 SWITZERLAND INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 323 SWITZERLAND STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 324 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 325 SWITZERLAND ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 326 SWITZERLAND ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 327 SWITZERLAND ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 328 SWITZERLAND BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 329 SWITZERLAND BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 330 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 331 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 332 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 333 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 334 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 335 SWITZERLAND CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 336 SWITZERLAND CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 337 SWITZERLAND ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 338 SWITZERLAND ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 339 SWITZERLAND DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 340 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 341 SWITZERLAND CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 342 SWITZERLAND CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 343 SWITZERLAND CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 344 SWITZERLAND CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 345 SWITZERLAND MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 346 SWITZERLAND MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 347 SWITZERLAND NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 348 SWITZERLAND NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 349 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 350 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 351 SWITZERLAND HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 352 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 353 RUSSIA SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 354 RUSSIA INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 355 RUSSIA STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 356 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 357 RUSSIA ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 358 RUSSIA ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 359 RUSSIA ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 360 RUSSIA BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 361 RUSSIA BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 362 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 363 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 364 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 365 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 366 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 367 RUSSIA CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 368 RUSSIA CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 369 RUSSIA ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 370 RUSSIA ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 371 RUSSIA DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 372 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 373 RUSSIA CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 374 RUSSIA CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 375 RUSSIA CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 376 RUSSIA CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 377 RUSSIA MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 378 RUSSIA MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 379 RUSSIA NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 380 RUSSIA NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 381 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 382 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 383 RUSSIA HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 384 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 385 TURKEY SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 386 TURKEY INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 387 TURKEY STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 388 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 389 TURKEY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 390 TURKEY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 391 TURKEY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 392 TURKEY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 393 TURKEY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 394 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 395 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 396 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 397 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 398 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 399 TURKEY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 400 TURKEY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 401 TURKEY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 402 TURKEY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 403 TURKEY DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 404 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 405 TURKEY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 406 TURKEY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 407 TURKEY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 408 TURKEY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 409 TURKEY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 410 TURKEY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 411 TURKEY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 412 TURKEY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 413 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 414 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 415 TURKEY HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 416 REST OF EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
Список рисунков
FIGURE 1 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION
FIGURE 2 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: DATA TRIANGULATION
FIGURE 3 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: DROC ANALYSIS
FIGURE 4 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: REGIONAL AND COUNTRY LEVEL MARKET ANALYSIS
FIGURE 5 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: COUNTRY LEVEL MARKET ANALYSIS
FIGURE 6 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: REGIONAL AND COUNTRY LEVEL MARKET ANALYSIS
FIGURE 7 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 8 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: DBMR MARKET POSITION GRID
FIGURE 10 JAPAN LIFELINE CURVE
FIGURE 11 EUROPE LIFELINE CURVE
FIGURE 12 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: MARKET END USER COVERAGE GRID
FIGURE 13 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION
FIGURE 14 INCREASING TECHNOLOGICAL ADVANCEMENTS IS DRIVING THE GROWTH OF U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031
FIGURE 16 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031
FIGURE 17 SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031
FIGURE 18 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031
FIGURE 19 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031
FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET
FIGURE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023
FIGURE 22 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023
FIGURE 23 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023
FIGURE 24 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)
FIGURE 25 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)
FIGURE 26 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)
FIGURE 27 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 28 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE CAGR (2024-2031)
FIGURE 29 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 31 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 32 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 33 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023
FIGURE 34 JAPAN ORTHOTIC DEVICES MARKET: BY IMAGING MODALITY, 2023
FIGURE 35 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023
FIGURE 36 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)
FIGURE 37 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)
FIGURE 38 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)
FIGURE 39 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031)
FIGURE 40 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY CAGR (2024-2031)
FIGURE 41 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031)
FIGURE 42 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE
FIGURE 43 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE
FIGURE 44 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE
FIGURE 45 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023
FIGURE 46 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023
FIGURE 47 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023
FIGURE 48 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (U.S.D MILLION)
FIGURE 49 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (U.S.D MILLION)
FIGURE 50 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (U.S.D MILLION)
FIGURE 51 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 52 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION CAGR (2024-2031)
FIGURE 53 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 54 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 55 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 56 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 57 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023
FIGURE 58 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023
FIGURE 59 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023
FIGURE 60 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
FIGURE 61 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
FIGURE 62 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
FIGURE 63 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)
FIGURE 64 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE CAGR (2024-2031)
FIGURE 65 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)
FIGURE 66 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 67 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 68 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 69 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023
FIGURE 70 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023
FIGURE 71 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023
FIGURE 72 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 73 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 74 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 75 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)
FIGURE 76 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)
FIGURE 77 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)
FIGURE 78 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE
FIGURE 79 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE
FIGURE 80 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE
FIGURE 81 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: SNAPSHOT (2023)
FIGURE 82 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)
FIGURE 83 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)
FIGURE 84 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)
FIGURE 85 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
